Menu
Back to Journals » Therapeutics and Clinical Risk Management » Volume 18
Review
A Profile of Avelumab Plus Axitinib in the Treatment of Renal Cell Carcinoma
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 5,758 | Dovepress* | 5,320+ | 232 | 5,552 | |
| PubMed Central* | 438 | 112 | 550 | ||
| Totals | 5,758 | 344 | 6,102 | ||
| *Since 8 July 2022 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar